Bwxt Medical Ltd, based in Canada, is a pharmaceutical company.
One of their notable products is INDIUM-111 CHLORIDE, with a corresponding US DMF Number 5542.
Remarkably, this DMF maintains an Active status since its submission on September 27, 1984, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2019, and payment made on October 24, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II